Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Arvind Dasari, Chan Shen, Daniel M. Halperin et al. · JAMA Oncology · 2017 · 3.5K citations · Full text

Medicine, Oncology, Surgery +17

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019

Pedro Pimentel‐Nunes, Diogo Libânio, Ricardo Marcos‐Pinto et al. · Endoscopy · 2019 · 968 citations · Full text

Medicine, Oncology, Pathology +15

Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study

Guido Rindi, Ombretta Luinetti, Matteo Cornaggia et al. · Gastroenterology · 1993 · 643 citations

Medicine, Oncology, Pathology +16

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

U.-F. Pape, Uta Berndt, Jacqueline Müller‐Nordhorn et al. · Endocrine Related Cancer · 2008 · 382 citations · Full text

Medicine, Oncology, Pathology +17

Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate

Elettra Merola, Andrea Sbrozzi-Vanni, Francesco Panzuto et al. · Neuroendocrinology · 2011 · 131 citations · Full text

Medicine, Oncology, Surgery +17